Related Experiment Video
Updated: Aug 8, 2026
07:21
Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
Published on: June 30, 2021
Production methods for gene transfer vectors based on adeno-associated virus serotypes
1Department of Pediatrics, School of Medicine, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA. dgrimm@stanford.edu
Methods (San Diego, Calif.)
|November 5, 2002
Summary
Researchers are exploring alternative adeno-associated virus (AAV) serotypes beyond AAV-2 for improved human gene transfer. New methods allow production of these novel AAV vectors, overcoming limitations of AAV-2.
Area of Science:
- Gene Therapy
- Virology
- Molecular Biology
Background:
- Adeno-associated virus serotype 2 (AAV-2) vectors show promise for human gene transfer due to low toxicity and long-term expression.
- However, AAV-2 vectors exhibit inefficient transduction in certain cell types and are often hindered by pre-existing neutralizing antibodies in the human population.
Purpose of the Study:
- To describe and compare methodologies for producing alternative adeno-associated virus (AAV) vectors in tissue culture.
- To overcome the limitations associated with AAV-2 vectors for improved human gene transfer applications.
Main Methods:
- Tissue culture production of alternative AAV vectors using two or three plasmid transfection strategies.
- Comparison of protocols for generating "real" serotypes and "pseudotyped" vectors with cross-packaged DNA into different AAV capsids.
Main Results:
- Established protocols for producing alternative AAV vectors, including "real" serotypes and "pseudotyped" vectors.
- Demonstrated feasibility of packaging recombinant AAV genomes into heterologous capsids.
Conclusions:
- Alternative AAV serotypes offer potential solutions to AAV-2 vector limitations in human gene transfer.
- Current production methods are promising but require further development and optimization for broader clinical application.
